Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells.
Saleh HA, Mitwasi N, Ullrich M, Kubeil M, Toussaint M, Deuther-Conrad W, Neuber C, Arndt C, R Loureiro L, Kegler A, González Soto KE, Belter B, Rössig C, Pietzsch J, Frenz M, Bachmann M, Feldmann A.
Saleh HA, et al. Among authors: kubeil m.
Front Immunol. 2023 Apr 14;14:1166169. doi: 10.3389/fimmu.2023.1166169. eCollection 2023.
Front Immunol. 2023.
PMID: 37122703
Free PMC article.